ContraFect Corporation (CFRX)
NASDAQ
YONKERS, N.Y., Oct. 16, 2023 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.2318 | 0.2318 | 0.2318 | 0 | 0 | CS |
4 | 0 | 0 | 0.2318 | 0.2318 | 0.2318 | 0 | 0 | CS |
12 | 0 | 0 | 0.2318 | 0.2318 | 0.2318 | 0 | 0 | CS |
26 | 0 | 0 | 0.2318 | 0.2318 | 0.2318 | 0 | 0 | CS |
52 | -0.3312 | -58.8277087034 | 0.563 | 0.6708 | 0.2 | 46276 | 0.43979057 | CS |
156 | -314.1682 | -99.9262722646 | 314.4 | 363.2 | 0.2 | 1564231 | 15.65803615 | CS |
260 | -32.9682 | -99.3018072289 | 33.2 | 1060 | 0.2 | 1152322 | 65.98919395 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.